Episurf
ISIN: SE0003491562 | Ticker: EPIS | LEI: 549300GORBCSMHZB2J75
Country: Sweden
Episurf Medical is endeavouring to bring people with painful joint injuries a more active, healthier life through the availability of minimally invasive and personalized treatment alternatives. Episurf Medical’s Episealer personalised endoprostheses and Epiguide surgical drill guides are used for treating localised cartilage injury in joints following precise 3D modelling. Episurf Medical’s μiFidelity system will enable endoprostheses to be cost-efficiently tailored to each individual’s unique injury for the optimal fit and minimal intervention.
HeadquartersKarlavägen 60, 11449 Stockholm – Sweden
| Line item in (sek) | 01.01.2020 | 01.01.2021 | 01.01.2022 | 01.01.2023 |
|---|---|---|---|---|
| Assets | N/A | 185,400,000.00 | 270,600,000.00 | 197,200,000.00 |
| Noncurrent Assets | N/A | 25,100,000.00 | 26,300,000.00 | 36,200,000.00 |
| Office Equipment | N/A | 0.00 | 100,000.00 | N/A |
| Intangible Assets Other Than Goodwill | N/A | 20,800,000.00 | 23,000,000.00 | 29,500,000.00 |
| Intangible Assets Under Development | N/A | 6,700,000.00 | 9,000,000.00 | N/A |
| Other Noncurrent Receivables | N/A | 500,000.00 | 0.00 | N/A |
| Current Assets | N/A | 160,300,000.00 | 244,400,000.00 | 161,000,000.00 |
| Inventories | N/A | 2,000,000.00 | 1,900,000.00 | 1,900,000.00 |
| Current Trade Receivables | N/A | 600,000.00 | 1,600,000.00 | 1,900,000.00 |
| Other Current Receivables | N/A | 900,000.00 | 1,600,000.00 | 900,000.00 |
| Cash and cash equivalents | 25,300,000.00 | 155,000,000.00 | 237,900,000.00 | 155,300,000.00 |
| Equity And Liabilities | N/A | 185,400,000.00 | 270,600,000.00 | 197,200,000.00 |
| Equity | 41,400,000.00 | 169,500,000.00 | 252,800,000.00 | 177,700,000.00 |
| Issued Capital | N/A | 66,700,000.00 | 80,000,000.00 | 80,100,000.00 |
| Retained Earnings | N/A | -443,200,000.00 | -511,300,000.00 | -587,000,000.00 |
| Other Reserves | N/A | -200,000.00 | -300,000.00 | -200,000.00 |
| Additional Paidin Capital | N/A | 546,200,000.00 | 684,400,000.00 | 684,800,000.00 |
| Liabilities | N/A | 16,000,000.00 | 17,800,000.00 | 19,500,000.00 |
| Noncurrent Liabilities | N/A | 2,100,000.00 | 3,500,000.00 | 4,800,000.00 |
| Other Noncurrent Liabilities | N/A | 600,000.00 | 2,800,000.00 | 1,000,000.00 |
| Current Liabilities | N/A | 13,900,000.00 | 14,200,000.00 | 14,700,000.00 |
| Trade And Other Current Payables To Trade Suppliers | N/A | 5,400,000.00 | 5,900,000.00 | 4,400,000.00 |
| Current Accruals And Current Deferred Income Including Current Contract Liabilities | N/A | N/A | 4,900,000.00 | 6,000,000.00 |
| Other Current Liabilities | N/A | 2,300,000.00 | 1,400,000.00 | 1,800,000.00 |
| Line item in (sek) | 01.01.2020/ 01.01.2021 |
01.01.2021/ 01.01.2022 |
01.01.2022/ 01.01.2023 |
|---|---|---|---|
| Revenue | 5,000,000.00 | 6,500,000.00 | 6,600,000.00 |
| Other Income | 2,000,000.00 | 400,000.00 | 300,000.00 |
| Other Work Performed By Entity And Capitalised | 4,100,000.00 | 6,900,000.00 | 11,300,000.00 |
| Cost Of Merchandise Sold | 5,100,000.00 | 4,800,000.00 | 4,200,000.00 |
| Employee Benefits Expense | 28,300,000.00 | 33,900,000.00 | 40,300,000.00 |
| Depreciation And Amortisation Expense | 7,600,000.00 | 7,400,000.00 | 7,400,000.00 |
| Other Expense By Nature | 33,500,000.00 | 37,100,000.00 | 43,300,000.00 |
| Profit Loss From Operating Activities | -63,400,000.00 | -69,400,000.00 | -77,000,000.00 |
| Finance Income | 100,000.00 | 400,000.00 | 500,000.00 |
| Finance Costs | 700,000.00 | 200,000.00 | 700,000.00 |
| Profit Loss Before Tax | -63,900,000.00 | -69,200,000.00 | -77,200,000.00 |
| Income Tax Expense Continuing Operations | 0.00 | 0.00 | 100,000.00 |
| Profit (loss) | -63,900,000.00 | -69,300,000.00 | -77,300,000.00 |
| Line item in (sek) | 01.01.2020 | 01.01.2021 | 01.01.2022 | 01.01.2023 |
|---|---|---|---|---|
| Profit (loss) | N/A | -63,900,000.00 | -69,300,000.00 | -77,300,000.00 |
| Adjustments For Decrease Increase In Inventories | N/A | -200,000.00 | 0.00 | 100,000.00 |
| Adjustments For Decrease Increase In Other Operating Receivables | N/A | -800,000.00 | -600,000.00 | 1,500,000.00 |
| Adjustments For Increase Decrease In Other Operating Payables | N/A | 1,000,000.00 | 800,000.00 | -400,000.00 |
| Adjustments For Depreciation And Amortisation Expense | N/A | 7,600,000.00 | 7,400,000.00 | 7,400,000.00 |
| Adjustments For Sharebased Payments | N/A | 1,400,000.00 | 3,300,000.00 | -200,000.00 |
| Interest Paid Classified As Operating Activities | N/A | 0.00 | 200,000.00 | 600,000.00 |
| Interest Received Classified As Operating Activities | N/A | 0.00 | 100,000.00 | 100,000.00 |
| Cash Flows From Used In Operating Activities | N/A | -54,100,000.00 | -59,700,000.00 | -69,500,000.00 |
| Purchase Of Property Plant And Equipment Classified As Investing Activities | N/A | 0.00 | 100,000.00 | 0.00 |
| Purchase Of Intangible Assets Classified As Investing Activities | N/A | 4,600,000.00 | 6,900,000.00 | 11,300,000.00 |
| Cash Flows From Used In Investing Activities | N/A | -5,100,000.00 | -6,500,000.00 | -11,200,000.00 |
| Proceeds From Issuing Shares | N/A | 190,900,000.00 | 150,600,000.00 | 0.00 |
| Proceeds From Issuing Other Equity Instruments | N/A | 100,000.00 | 900,000.00 | 0.00 |
| Payments Of Lease Liabilities Classified As Financing Activities | N/A | 2,200,000.00 | 2,400,000.00 | 2,400,000.00 |
| Cash Flows From Used In Financing Activities | N/A | 188,800,000.00 | 149,200,000.00 | -1,900,000.00 |
| Increase (decrease) in cash and cash equivalents after effect of exchange rate changes | N/A | 129,700,000.00 | 83,000,000.00 | -82,600,000.00 |
| Cash and cash equivalents | 25,300,000.00 | 155,000,000.00 | 237,900,000.00 | 155,300,000.00 |
Please note that some sums might not add up.
| Date | Trading entity / Person | Association | Trade type | Volume |
|---|---|---|---|---|
| 10.05.23 | Laura Shunk | Other | Buy | USD 7,800.00 |
| 08.05.23 | Pål Ryfors | Other | Buy | SEK 203,180.06 |
| 05.05.23 | Pål Ryfors | Other | Buy | SEK 81,155.00 |
| 05.05.23 | Pål Ryfors | Other | Buy | SEK 79,685.00 |
| 05.05.23 | Pål Ryfors | Other | Buy | SEK 79,000.00 |
| 05.05.23 | Pål Ryfors | Other | Buy | SEK 78,400.00 |
| 05.05.23 | Pål Ryfors | Other | Buy | SEK 78,270.00 |
| 05.05.23 | Pål Ryfors | Other | Buy | SEK 61,368.42 |
| 22.02.23 | Leif Ryd | Other | Buy | SEK 108,500.00 |
| 22.02.23 | Leif Ryd | Other | Buy | SEK 54,250.00 |
SE0003491562
LEI549300GORBCSMHZB2J75
SectorHealth Care Equipment & Services
IndustryKeep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.